You are here: Industry Insights > CEPI

News List

Dynavax, Queensland University and CEPI work on Covid-19 vaccine pharmaceutical-technology
March 04, 2020
Biopharmaceutical firm Dynavax Technologies has partnered with the University of Queensland (UQ) and Coalition for Epidemic Preparedness (CEPI) for the development of a Covid-19 vaccine.
Valneva secures CEPI grant to develop Chikungunya vaccine pharmaceutical-technology
July 26, 2019
French biotech firm Valneva has received a grant of up to $23.4m from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a single-dose, live-attenuated Chikungunya vaccine.
CEPI and Imperial College London collaborate on Disease X vaccines project pharmaceutical-technology
December 11, 2018
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and Imperial College London have formed an alliance to develop new vaccines against known as well as unknown......
Global coalition backs Imperial College London’s RNA vaccine platform to fight ‘Disease X’ fiercepharma
December 11, 2018
One of the first missions that the Coalition for Epidemic Preparedness Innovations (CEPI) set when it came into being in 2017 was to facilitate development of vaccine platforms that can be quickly adopted
CEPI, Imperial College partner for emerging diseases vaccines pharmatimes
December 11, 2018
The Coalition for Epidemic Preparedness Innovations (CEPI) and Imperial College London have announced a partnership to develop a self-amplifying RNA vaccine platform (saRNA), enabling tailored vaccine production against multiple viral pathogens.
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
November 09, 2018
CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 29, 2018
CEPI, the global outbreak preparedness group, has been busy since it launched last year, raising more than $600 million and handing out grants to back research into neglected diseases. In its latest move, the coalition awarded ...
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 28, 2018
J&J and Oxford University snagged $18.7 million for work on MERS, Lassa and Nipah vaccines.
CEPI, Emergent and Profectus Enter Vaccine Mfg. pact contractpharma
August 22, 2018
CEPI (the Coalition for Epidemic Preparedness Innovations) has unveiled a new collaboration with Profectus BioSciences and Emergent BioSolutionsunder.......
Profectus, Emergent BioSolutions and PATH join forces in search for a Nipah vaccine fiercepharma
May 30, 2018
Outbreak-focused Coalition for Epidemic Preparedness Innovations (CEPI) has already shelled out three times to support research on MERS and Lassa fever vaccines.

Previous page 1 2 3 4 5 Next page